ARTICLE | Clinical News
Solodyn minocycline regulatory update
May 15, 2006 7:00 AM UTC
FDA approved an NDA for Solodyn minocycline once-daily extended-release tablets to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. ...